Separation and inhibitor specificity of a second unidirectional efflux route for methotrexate in L1210 cells.
L1210 cells mediate the unidirectional and energy-dependent efflux of methotrexate. Efflux occurs primarily via a system which has a high sensitivity to prostaglandin A1, vincristine, reserpine, verapamil, and bromosulfophthalein, but evidence has also been obtained for a second efflux component with a lower response to these inhibitors. Pretreatment of L1210 cells with low concentrations of vincristine reduces methotrexate efflux by three fold and uncovers a second efflux component with an inhibitor specificity which is distinctly different from the primary efflux route. Vincristine treatment increased by 8-20-fold the concentration required for half-maximal efflux inhibition by prostaglandin A1, reserpine, bromosulfophthalein, and verapamil but had no effect on inhibition by probenecid, quinidine, or carbonylcyanide m-chlorophenylhydrazone. A selective block in the primary efflux system and retention of the second component was also achieved in cells exposed to low concentrations of prostaglandin A1 or bromosulfophthalein. These results support prior conclusions that L1210 cells contain both a primary and secondary unidirectional efflux route for methotrexate. The second system has been difficult to detect and quantitate since it comprises only 25% of total unidirectional efflux and shows a relatively low response to various efflux inhibitors.
Henderson
G B
GB
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone / Q000494:pharmacology; D007939:Leukemia L1210; D008727:Methotrexate / Q000378:metabolism*; D051379:Mice; D011339:Probenecid / Q000494:pharmacology; D011454:Prostaglandins A / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013448:Sulfobromophthalein / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014700:Verapamil / Q000494:pharmacology; D014750:Vincristine / Q000494:pharmacology
D011454:Prostaglandins A; D013448:Sulfobromophthalein; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone; D014750:Vincristine; D012110:Reserpine; D000255:Adenosine Triphosphate; D014700:Verapamil; D011802:Quinidine; D011339:Probenecid; C100573:prostaglandin A1; D008727:Methotrexate